Enanta Pharmaceuticals Inc (ENTA) — DEFA14A Filings
All DEFA14A filings from Enanta Pharmaceuticals Inc. Browse 2 DEFA14A reports with AI-powered summaries and risk analysis.
DEFA14A Filings (2)
-
Enanta Pharma Files Additional Proxy Materials
— Jan 27, 2025 Risk: low
Enanta Pharmaceuticals, Inc. filed a Definitive Additional Materials proxy statement on January 27, 2025. This filing is related to materials previously submitt -
Enanta Pharma Sets March 6 Shareholder Meeting; Proxy Materials Online
— Jan 26, 2024
Enanta Pharmaceuticals Inc. (ENTA) has filed definitive additional proxy materials for its upcoming Stockholders Meeting on March 6, 2024. This filing, dated Ja
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX